PHOENIX--(BUSINESS WIRE)--Zila, Inc. (NASDAQ:ZILA) today announced that it plans to launch its proprietary oral cancer screening product, ViziLite® Plus with TBlue™, in the United Kingdom at the British Dental Conference & Exhibition, the British Dental Association’s annual conference, on May 1, 2008 in Manchester, England.
